The University of Chicago Header Logo

Connection

David Grdina to Carcinoma, Ehrlich Tumor

Back to Details
This is a "connection" page, showing publications David Grdina has written about Carcinoma, Ehrlich Tumor.
David Grdina
Connection Strength
0.005
Carcinoma, Ehrlich Tumor
  1. The development of alpha-emitting radionuclide lead 212 for the potential treatment of ovarian carcinoma. Am J Obstet Gynecol. 1989 Apr; 160(4):789-97.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.